Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 9, Number 10—October 2003


Syndromic Surveillance and Bioterrorism-related Epidemics

James W. Buehler*Comments to Author , Ruth L. Berkelman*, David M. Hartley†, and Clarence J. Peters‡
Author affiliations: *Emory University Rollins School of Public Health, Atlanta, Georgia, USA; †University of Maryland School of Medicine, Baltimore, Maryland, USA; ‡University of Texas Medical Branch, Galveston, Texas, USA

Main Article

Table 1

Outcome of initial contact with health care for anthrax-related illness and timing of anthrax diagnosis, 11 patients with inhalational anthrax, 2001a

Disposition after initial medical care No. of patients
Admitted to hospital
          Discharged home from ER, subsequent hospital admission
          Discharged home from outpatient provider, subsequent hospital admission

Anthrax diagnosis

          Blood or CSF culture on hospital admission, presumptive diagnosis <24 h
          Blood culture from preceding ER visit, patient recalled for admission
          Prior antibiotic therapy; clinical suspicion of anthrax; specialized test required to establish diagnosis
          Total 11

aER, emergency room; CSF, cerebrospinal fluid.

Main Article

1For interval calculations, if reported event dates were discrepant in different case reports, dates reported by Jernigan et al. (13) were used.

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO